Nitroxyl (HNO): A reduced form of nitric oxide with distinct chemical, pharmacological, and therapeutic properties

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Shoman, Mai E ^a   Aly, Omar M ^a  

^a Minia University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; HEALTH CARE; MEDICINE;

BIOLOGICAL ACTIONS; CHEMICAL AND BIOLOGICALS; HEART FAILURE; NITROXYL; THERAPEUTIC PROPERTIES;

NITRIC OXIDE;

ACYL NITROSO COMPOUND; ACYLOXY NITROSO COMPOUND; ANGELI S SALT; CYANAMIDE; DIAZENIUMDIOLATE; INOTROPIC AGENT; NITRIC OXIDE; NITROSO DERIVATIVE; NITROXYL; PHOSPHINE DERIVATIVE; PILOTY S ACID; SODIUM CHLORIDE; THIOL; UNCLASSIFIED DRUG; VASODILATOR AGENT; NITROGEN OXIDE;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; BIOLOGICAL ACTIVITY; HEART FUNCTION; REPERFUSION INJURY; REVIEW; THROMBOCYTE AGGREGATION; CHEMISTRY; METABOLISM; OXIDATION REDUCTION REACTION;

NITRIC OXIDE; NITROGEN OXIDES; OXIDATION-REDUCTION;

EID: 84953311113     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/4867124     Document Type: Review

References (134)

1. J. M. Fukuto, C. L. Bianco, and T. A. Chavez, Nitroxyl (HNO) signaling, Free Radical Biology and Medicine, vol. 47, no. 9, pp. 1318-1324, 2009.
2. J. M. Fukuto, M. D. Bartberger, A. S. Dutton, N. Paolocci, D. A. Wink, and K. N. Houk, The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood, and enigmatic nitrogen oxide, Chemical Research in Toxicology, vol. 18, no. 5, pp. 790-801, 2005.
3. O. W. Griffith and D. J. Stuehr, Nitric oxide synthases: properties and catalytic mechanism, Annual Review of Physiology, vol. 57, pp. 707-736, 1995.
4. S. Moncada and E. A. Higgs, Endogenous nitric oxide: physiology, pathology and clinical relevance, European Journal of Clinical Investigation, vol. 21, no. 4, pp. 361-374, 1991.
5. W. P. Arnold, C. K. Mittal, S. Katsuki, and F. Murad, Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations, Proceedings of the National Academy of Sciences of the United States of America, vol. 74, no. 8, pp. 3203-3207, 1977.
6. G. R. J. Thatcher, NOproblem for nitroglycerin: organic nitrate chemistry and therapy, Chemical Society Reviews, vol. 27, no. 5, pp. 331-337, 1998.
7. M. A. Moro, R. J. R. Russell, S. Cellek et al., cGMPmediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase, Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 4, pp. 1480-1485, 1996.
8. M. Rosselli, P. J. Keller, and R. K. Dubey, Role of nitric oxide in the biology, physiology and pathophysiology of reproduction, Human Reproduction Update, vol. 4, no. 1, pp. 3-24, 1998.
9. N. Paolocci, M. I. Jackson, B. E. Lopez et al., The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO1, Pharmacology andTherapeutics, vol. 113, no. 2, pp. 442-458, 2007.
10. J. M. Fukuto, A. S. Dutton, and K. N. Houk, The chemistry and biology of nitroxyl (HNO): a chemically unique species with novel and important biological activity, ChemBioChem, vol. 6, no. 4, pp. 612-619, 2005.
11. N. Y. Spencer, N. K. Patel, A. Keszler, and N. Hogg, Oxidation and nitrosylation of oxyhemoglobin by S-nitrosoglutathione via nitroxyl anion, Free Radical Biology and Medicine, vol. 35, no. 11, pp. 1515-1526, 2003.
12. P. Gross and R. P. Smith, Biologic activity of hydroxylamine: a review, Critical Reviews in Toxicology, vol. 14, no. 1, pp. 87-99, 1985.
13. J. C. Irvine, R. H. Ritchie, J. L. Favaloro, K. L. Andrews, R. E. Widdop, and B. K. Kemp-Harper, Nitroxyl (HNO): the Cinderella of the nitric oxide story, Trends in Pharmacological Sciences, vol. 29, no. 12, pp. 601-608, 2008.
14. A. Angeli, Sopra la nitroidrossilammina, Gazzetta Chimica Italiana, vol. 26, pp. 17-25, 1896.
15. A. A. A. F. Angelico, Nuove ricerche sopra lacido nitroidrossilamminico, Gazzetta Chimica Italiana, vol. 33, p. 245, 1903.
16. A. S. Dutton, J. M. Fukuto, and K. N. Houk, Mechanisms of HNO and NO production from Angelis salt: density functional and CBS-QB3 theory predictions, Journal of the American Chemical Society, vol. 126, no. 12, pp. 3795-3800, 2004.
17. K. M. Miranda, The chemistry of nitroxyl (HNO) and implications in biology, Coordination Chemistry Reviews, vol. 249, no. 3-4, pp. 433-455, 2005.
18. D. A. Wink, K. M. Miranda, T. Katori et al., Orthogonal properties of the redox siblings nitroxyl and nitric oxide in the cardiovascular system: a novel redox paradigm, The American Journal of Physiology-Heart and Circulatory Physiology, vol. 285, no. 6, pp. H2264-H2276, 2003.
19. E. Cheong, V. Tumbev, J. Abramson, G. Salama, and D. A. Stoyanovsky, Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors, Cell Calcium, vol. 37, no. 1, pp. 87-96, 2005.
20. A. Arcaro, G. Lembo, and C. G. Tocchetti, Nitroxyl (HNO) for treatment of acute heart failure, Current Heart Failure Reports, vol. 11, no. 3, pp. 227-235, 2014.
21. M. Graetzel, S. Taniguchi, and A. Henglein, Pulse radiolytic study of short-lived by-products of nitric oxide-reduction in aqueous solution, Berichte der Bunsen-Gesellschaft, vol. 74, no. 10, pp. 1003-1010, 1970.
22. M. D. Bartberger, J. M. Fukuto, and K. N. Houk, On the acidity and reactivity of HNO in aqueous solution and biological systems, Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2194-2198, 2001.
23. M. D. Bartberger, W. Liu, E. Ford et al., The reduction potential of nitric oxide (NO) and its importance to NO biochemistry, Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 17, pp. 10958-10963, 2002.
24. V. Shafirovich and S. V. Lymar, Nitroxyl and its anion in aqueous solutions: spin states, protic equilibria, and reactivities toward oxygen and nitric oxide, Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 11, pp. 7340-7345, 2002.
25. K. M. Miranda, N. Paolocci, T. Katori et al., A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system, Proceedings of theNational Academy of Sciences of the United States of America, vol. 100, no. 16, pp. 9196-9201, 2003.
26. P. S. Wong, J. Hyun, J. M. Fukuto et al., Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry, Biochemistry, vol. 37, no. 16, pp. 5362-5371, 1998.
27. S. Donzelli, M. G. Espey, D. D. Thomas et al., Discriminating formation of HNO from other reactive nitrogen oxide species, Free Radical Biology andMedicine, vol. 40, no. 6, pp. 1056-1066, 2006.
28. C. H. Switzer, W. Flores-Santana, D. Mancardi et al., The emergence of nitroxyl (HNO) as a pharmacological agent, Biochimica et Biophysica Acta-Bioenergetics, vol. 1787, no. 7, pp. 835-840, 2009.
29. F. T. Bonner and B. Ravid, Thermal decomposition of oxyhyponitrite (sodium trioxodinitrate(II)) in aqueous solution, Inorganic Chemistry, vol. 14, no. 3, pp. 558-563, 1975.
30. K. M. Miranda, H. T. Nagasawa, and J. P. Toscano, Donors of HNO, Current Topics in Medicinal Chemistry, vol. 5, no. 7, pp. 649-664, 2005.
31. E. G. DeMaster, B. Redfern, and H. T. Nagasawa, Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide, Biochemical Pharmacology, vol. 55, no. 12, pp. 2007-2015, 1998.
32. H. T. Nagasawa, E. G. DeMaster, B. Redfern, F. N. Shirota, and D. J. W. Goon, Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide, Journal of Medicinal Chemistry, vol. 33, no. 12, pp. 3120-3122, 1990.
33. C. M. Maragos, D. Morley, D. A. Wink et al., Complexes of ·NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects, Journal ofMedicinal Chemistry, vol. 34, no. 11, pp. 3242-3247, 1991.
34. D. Morley, C. M. Maragos, X. Y. Zhang, M. Boignon, D. A. Wink, and L. K. Keefer, Mechanism of vascular relaxation induced by the nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators, Journal of Cardiovascular Pharmacology, vol. 21, no. 4, pp. 670-676, 1993.
35. J. G. Giodati, A. A. Quyyumi, N. Hussain, and L. K. Keefer, Complexes of nitric oxide with nucleophiles as agents for the controlled biological release of nitric oxide: antiplatelet effect, Thrombosis and Haemostasis, vol. 70, no. 4, pp. 654-658, 1993.
36. K. M. Miranda, T. Katori, C. L. Torres de Holding et al., Comparison of the NO and HNO donating properties of diazeniumdiolates: primary amine adducts release HNO in vivo, Journal of Medicinal Chemistry, vol. 48, no. 26, pp. 8220-8228, 2005.
37. A. S. Dutton, C. P. Suhrada, K. M. Miranda, D. A. Wink, J. M. Fukuto, and K. N. Houk, Mechanism of pH-dependent decomposition of monoalkylamine diazeniumdiolates to form HNO and NO, deduced from the model compound methylamine diazeniumdiolate, density functional theory, and CBSQB3 calculations, Inorganic Chemistry, vol. 45, no. 6, pp. 2448-2456, 2006.
38. D. A. Wink, K. S. Kasprzak, C. M. Maragos et al., DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science, vol. 254, no. 5034, pp. 1001-1003, 1991.
39. S. B. King, N-hydroxyurea and acyl nitroso compounds as nitroxyl (HNO) and nitric oxide (NO) donors, Current Topics in Medicinal Chemistry, vol. 5, no. 7, pp. 665-673, 2005.
40. X. Sha, T. S. Isbell, R. P. Patel, C. S. Day, and S. B. King, Hydrolysis of acyloxy nitroso compounds yields nitroxyl (HNO), Journal of the American Chemical Society, vol. 128, no. 30, pp. 9687-9692, 2006.
41. H. A. H. Mohamed, M. Abdel-Aziz, A. A. Gamal El-Din, and S. B. King, Newacyloxy nitroso compounds with improved water solubility and nitroxyl (HNO) release kinetics and inhibitors of platelet aggregation, Bioorganic and Medicinal Chemistry, vol. 23, no. 17, pp. 6069-6077, 2015.
42. G. Calvet, M. Dussaussois, N. Blanchard, and C. Kouklovsky, Lewis acid-promoted hetero Diels-Alder cycloaddition of α-acetoxynitroso dienophiles, Organic Letters, vol. 6, no. 14, pp. 2449-2451, 2004.
43. M. E. Shoman, J. F. Dumond, T. S. Isbell et al., Acyloxy nitroso compounds as nitroxyl (HNO) donors: kinetics, reactions with thiols, and vasodilation properties, Journal of Medicinal Chemistry, vol. 54, no. 4, pp. 1059-1070, 2011.
44. H. P. Kim, S. W. Ryter, and A. M. Choi, CO as a cellular signaling molecule, Annual Review of Pharmacology and Toxicology, vol. 46, no. 1, pp. 411-449, 2006.
45. R. Wang, The gasotransmitter role of hydrogen sulfide, Antioxidants and Redox Signaling, vol. 5, no. 4, pp. 493-501, 2003.
46. K. L. Andrews, J. C. Irvine, M. Tare et al., A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries, British Journal of Pharmacology, vol. 157, no. 4, pp. 540-550, 2009.
47. S. Adak, Q. Wang, and D. J. Stuehr, Arginine conversion to nitroxide by tetrahydrobiopterin-free neuronal nitric-oxide synthase. Implications for mechanism, Journal of Biological Chemistry, vol. 275, no. 43, pp. 33554-33561, 2000.
48. A. J. Hobbs, J. M. Fukuto, and L. J. Ignarro, Formation of free nitric oxide from L-arginine by nitric oxide synthase: direct enhancement of generation by superoxide dismutase, Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 23, pp. 10992-10996, 1994.
49. H. H. Schmidt, H. Hofmann, U. Schindler, Z. S. Shutenkom, D. D. Cunningham, and M. Feelisch, No NO fromNO synthase, Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 25, pp. 14492-14497, 1996.
50. R. A. Pufahl, J. S. Wishnok, and M. A. Marletta, Hydrogen peroxide-supported oxidation of NG-hydroxy-l-arginine by nitric oxide synthase, Biochemistry, vol. 34, no. 6, pp. 1930-1941, 1995.
51. K. M. Rusche, M. M. Spiering, and M. A. Marletta, Reactions catalyzed by tetrahydrobiopterin-free nitric oxide synthase, Biochemistry, vol. 37, no. 44, pp. 15503-15512, 1998.
52. J. M. Fukuto, D. J. Stuehr, P. L. Feldman, M. P. Bova, and P. Wong, Peracid oxidation of an N-hydroxyguanidine compound: a chemical model for the oxidation of N omega-hydroxyl-Larginine by nitric oxide synthase, Journal of Medicinal Chemistry, vol. 36, no. 18, pp. 2666-2670, 1993.
53. D. A. Wink, M. Feelisch, J. Fukuto et al., The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO, Archives of Biochemistry and Biophysics, vol. 351, no. 1, pp. 66-74, 1998.
54. M. A. Sharpe and C. E. Cooper, Reactions of nitric oxide with mitochondrial cytochrome c: a novel mechanism for the formation of nitroxyl anion and peroxynitrite, Biochemical Journal, vol. 332, part 1, pp. 9-19, 1998.
55. M. Saleem and H. Ohshima, Xanthine oxidase converts nitric oxide to nitroxyl that inactivates the enzyme, Biochemical and Biophysical Research Communications, vol. 315, no. 2, pp. 455-462, 2004.
56. V. Niketic, S. Stojanovic, A. Nikolic, M. Spasic, and A. M. Michelson, Exposure ofMn and FeSODs, but not Cu/ZnSOD, to NO leads to nitrosonium and nitroxyl ions generation which cause enzyme modification and inactivation: an in vitro study, Free Radical Biology andMedicine, vol. 27, no. 9-10, pp. 992-996, 1999.
57. J. J. Poderoso, M. C. Carreras, F. Schopfer et al., The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance, FreeRadical Biology andMedicine, vol. 26, no. 7-8, pp. 925-935, 1999.
58. J. A. Reisz, E. Bechtold, and S. B. King, Oxidative heme proteinmediated nitroxyl (HNO) generation, Dalton Transactions, vol. 39, no. 22, pp. 5203-5212, 2010.
59. M. P. Doyle, S. N. Mahapatro, R. D. Broene, and J. K. Guy, Oxidation and reduction of hemoproteins by trioxodinitrate(II). The role of nitrosyl hydride and nitrite, Journal of the American Chemical Society, vol. 110, no. 2, pp. 593-599, 1988.
60. D. W. Shoeman, F. N. Shirota, E. G. DeMaster, and H. T. Nagasawa, Reaction of nitroxyl, an aldehyde dehydrogenase inhibitor, with N-acetyl-L-cysteine, Alcohol, vol. 20, no. 1, pp. 55-59, 2000.
61. T. Turk and T. C. Hollocher, Oxidation of dithiothreitol during turnover of nitric oxide reductase: evidence for generation of nitroxyl with the enzyme from Paracoccus denitrificans, Biochemical and Biophysical Research Communications, vol. 183, no. 3, pp. 983-988, 1992.
62. J. M. Fukuto, C. H. Switzer, K. M. Miranda, and D. A. Wink, Nitroxyl (HNO): chemistry, biochemistry, and pharmacology, Annual Reviewof Pharmacology and Toxicology, vol. 45, pp. 335-355, 2005.
63. B. Shen and A. M. English, Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines, Biochemistry, vol. 44, no. 42, pp. 14030-14044, 2005.
64. M. D. Hoffman, G. M. Walsh, J. C. Rogalski, and J. Kast, Identification of nitroxyl-induced modifications in human platelet proteins using a novel mass spectrometric detection method, Molecular and Cellular Proteomics, vol. 8, no. 5, pp. 887-903, 2009.
65. S. Mitroka, M. E. Shoman, J. F. DuMond et al., Direct and nitroxyl (HNO)-mediated reactions of acyloxy nitroso compounds with the thiol-containing proteins glyceraldehyde 3-phosphate dehydrogenase and alkyl hydroperoxide reductase subunit C, Journal of Medicinal Chemistry, vol. 56, no. 17, pp. 6583-6592, 2013.
66. W. Flores-Santana, C. Switzer, L. A. Ridnour et al., Comparing the chemical biology of NO and HNO, Archives of Pharmacal Research, vol. 32, no. 8, pp. 1139-1153, 2009.
67. M. P. Sherman, W. R. Grither, and R. D. McCulla, Computational investigation of the reaction mechanisms of nitroxyl and thiols, Journal of Organic Chemistry, vol. 75, no. 12, pp. 4014-4024, 2010.
68. P. J. Farmer and F. Sulc, Coordination chemistry of the HNO ligand with hemes and synthetic coordination complexes, Journal of Inorganic Biochemistry, vol. 99, no. 1, pp. 166-184, 2005.
69. K. M. Miranda, R. W. Nims, D. D. Thomas et al., Comparison of the reactivity of nitric oxide and nitroxyl with heme proteins: a chemical discussion of the differential biological effects of these redox related products of NOS, Journal of Inorganic Biochemistry, vol. 93, no. 1-2, pp. 52-60, 2003.
70. J. Huang, D. B. Kim-Shapiro, and S. B. King, Catalase-mediated nitric oxide formation from hydroxyurea, Journal of Medicinal Chemistry, vol. 47, no. 14, pp. 3495-3501, 2004.
71. S. E. Bari, M. A. Marti, V. T. Amorebieta, D. A. Estrin, and F. Doctorovich, Fast nitroxyl trapping by ferric porphyrins, Journal of the American Chemical Society, vol. 125, no. 50, pp. 15272-15273, 2003.
72. M. R. Filipovic, D. Stanic, S. Raicevic, M. Spasic, and V. Niketic, Consequences ofMnSOD interactions with nitric oxide: nitric oxide dismutation and the generation of peroxynitrite and hydrogen peroxide, Free Radical Research, vol. 41, no. 1, pp. 62-72, 2007.
73. M. M. Sidky, F. M. Soliman, and R. Shabana, Organophosphorus compounds. XXIV. The reaction of triphenylphosphine and trialkyl phosphites with α-nitroso-β-naphthol, Egyptian Journal of Chemistry, vol. 21, pp. 29-35, 1980.
74. E. Bechtold, J. A. Reisz, C. Klomsiri et al., Water-soluble triarylphosphines as biomarkers for protein S-nitrosation, ACS Chemical Biology, vol. 5, no. 4, pp. 405-414, 2010.
75. M. Haake, Zur desoxygenierung von tritylthionitrit, Tetrahedron Letters, vol. 13, no. 33, pp. 3405-3408, 1972.
76. J. A. Reisz, E. B. Klorlg, M. W. Wright, and S. B. King, Reductive phosphine-mediated ligation of nitroxyl (HNO), Organic Letters, vol. 11, no. 13, pp. 2719-2721, 2009.
77. K. M. Miranda, Y. K-I, M. G. Espey et al., Further evidence for distinct reactive intermediates from nitroxyl and peroxynitrite: effects of buffer composition on the chemistry of Angelis salt and synthetic peroxynitrite, Archives of Biochemistry and Biophysics, vol. 401, no. 2, pp. 134-144, 2002.
78. K. M. Miranda, A. S. Dutton, L. A. Ridnour et al., Mechanism of aerobic decomposition of Angelis salt (Sodium Trioxodinitrate) at physiological pH, Journal of the American Chemical Society, vol. 127, no. 2, pp. 722-731, 2005.
79. A. Reif, L. Zecca, P. Riederer, M. Feelisch, and H. H. H. W. Schmidt, Nitroxyl oxidizes NADPH in a superoxide dismutase inhibitable manner, Free Radical Biology andMedicine, vol. 30, no. 7, pp. 803-808, 2001.
80. J. Y. Cho, A. Dutton, T. Miller, K. N. Houk, and J. M. Fukuto, Oxidation of N-hydroxyguanidines by copper(II): model systems for elucidating the physiological chemistry of the nitric oxide biosynthetic intermediate N-hydroxyl-L-arginine, Archives of Biochemistry and Biophysics, vol. 417, no. 1, pp. 65-76, 2003.
81. R. Z. Pino and M. Feelisch, Bioassay discrimination between nitric oxide (NO) and nitroxyl (NO-) using L-cysteine, Biochemical and Biophysical Research Communications, vol. 201, no. 1, pp. 54-62, 1994.
82. A. M. Komarov, D. A. Wink, M. Feelisch, and H. H. H. W. Schmidt, Electron-paramagnetic resonance spectroscopy usingN-methyl-D-glucamine dithiocarbamate iron cannot discriminate between nitric oxide and nitroxyl: implications for the detection of reaction products for nitric oxide synthase, Free Radical Biology and Medicine, vol. 28, no. 5, pp. 739-742, 2000.
83. Y. Xia, A. J. Cardounel, A. F. Vanin, and J. L. Zweier, Electron paramagnetic resonance spectroscopy with N-methyl-D-glucamine dithiocarbamate iron complexes distinguishes nitric oxide and nitroxyl anion in a redox-dependent manner: applications in identifying nitrogen monoxide products from nitric oxide synthase, Free Radical Biology and Medicine, vol. 29, no. 8, pp. 793-797, 2000.
84. K. M. Miranda, M. G. Espey, K. Yamada et al., Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion, The Journal of Biological Chemistry, vol. 276, no. 3, pp. 1720-1727, 2001.
85. D. W. Shoeman and H. T. Nagasawa, The reaction of nitroxyl (HNO) with nitrosobenzene gives cupferron (NNitrosophenylhydroxylamine), Nitric Oxide, vol. 2, no. 1, pp. 66-72, 1998.
86. J. A. Reisz, C. N. Zink, and S. B. King, Rapid and selective nitroxyl (HNO) trapping by phosphines: kinetics and new aqueous ligations for HNO detection and quantitation, Journal of the American Chemical Society, vol. 133, no. 30, pp. 11675-11685, 2011.
87. G. M. Johnson, T. J. Chozinski, D. J. Salmon, A. D. Moghaddam, H. C. Chen, and K. M. Mirandan, Quantitative detection of nitroxyl upon trapping with glutathione and labeling with a specific fluorogenic reagent, FreeRadical Biology andMedicine, vol. 63, pp. 476-484, 2013.
88. M. R. Cline and J. P. Toscano, Detection of nitroxyl (HNO) by a prefluorescent probe, Journal of Physical Organic Chemistry, vol. 24, no. 10, pp. 993-998, 2011.
89. A. T. Wrobel, T. C. Johnstone, A. Deliz Liang, S. J. Lippard, and P. Rivera-Fuentes, Afast and selective near-infrared fluorescent sensor for multicolor imaging of biological nitroxyl (HNO), Journal of the American Chemical Society, vol. 136, no. 12, pp. 4697-4705, 2014.
90. M. J. C. Lee, H. T. Nagasawa, J. A. Elberling, and E. G. DeMaster, Prodrugs of nitroxyl as inhibitors of aldehyde dehydrogenase, Journal of Medicinal Chemistry, vol. 35, no. 20, pp. 3648-3652, 1992.
91. J. M. Fukuto, K. Chiang, R. Hszieh, P. Wong, and G. Chaudhuri, The pharmacological activity of nitroxyl: a potent vasodilator with activity similar to nitric oxide and/or endothelium-derived relaxing factor, Journal of Pharmacology and Experimental Therapeutics, vol. 263, no. 2, pp. 546-551, 1992.
92. J. C. Wanstall, T. K. Jeffery, A. Gambino, F. Lovren, and C. R. Triggle, Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion, British Journal of Pharmacology, vol. 134, no. 3, pp. 463-472, 2001.
93. A. Ellis, C. G. Li, and M. J. Rand, Differential actions of Lcysteine on responses to nitric oxide, nitroxyl anions and EDRF in the rat aorta, British Journal of Pharmacology, vol. 129, no. 2, pp. 315-322, 2000.
94. J. C. Irvine, J. L. Favaloro, and B. K. Kemp-Harper, NOactivates soluble guanylate cyclase andKv channels to vasodilate resistance arteries, Hypertension, vol. 41, no. 6, pp. 1301-1307, 2003.
95. J. L. Favaloro and B. K. Kemp-Harper, The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature, Cardiovascular Research, vol. 73, no. 3, pp. 587-596, 2007.
96. B. J. De Witt, J. R. Marrone, A. D. Kaye, L. K. Keefer, and P. J. Kadowitz, Comparison of responses to novel nitric oxide donors in the feline pulmonary vascular bed, European Journal of Pharmacology, vol. 430, no. 2-3, pp. 311-315, 2001.
97. X. L. Ma, F. Gao, G.-L. Liu et al., Opposite effects of nitric oxide and nitroxyl on postischemicmyocardial injury, Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 25, pp. 14617-14622, 1999.
98. N. Paolocci, T. Katori, H. C. Champion et al., Positive inotropic and lusitropic effects of HNO/NO-in failing hearts: independence from beta-adrenergic signaling, Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 9, pp. 5537-5542, 2003.
99. N. Paolocci, W. F. Saavedra, K. M. Miranda et al., Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling, Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 18, pp. 10463-10468, 2001.
100. K. L. Andrews, N. G. Lumsden, J. Farry, A. M. Jefferis, B. K. Kemp-Harper, and J. P. Chin-Dusting, Nitroxyl: a vasodilator of human vessels that is not susceptible to tolerance, Clinical Science (London), vol. 129, no. 2, pp. 179-187, 2015.
101. A. J. Hobbs, Soluble guanylate cyclase: the forgotten sibling, Trends in Pharmacological Sciences, vol. 18, no. 12, pp. 484-491, 1997.
102. E. A. Dierks and J. N. Burstyn, Nitric oxide (NO), the only nitrogen monoxide redox form capable of activating soluble guanylyl cyclase, Biochemical Pharmacology, vol. 51, no. 12, pp. 1593-1600, 1996.
103. J. C. Irvine, J. L. Favaloro, R. E. Widdop, and B. K. Kemp-Harper, Nitroxyl anion donor, Angelis salt, does not develop tolerance in rat isolated aortae, Hypertension, vol. 49, no. 4, pp. 885-892, 2007.
104. J.-P. Stasch, P. M. Schmidt, P. I. Nedvetsky et al., Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels, The Journal of Clinical Investigation, vol. 116, no. 9, pp. 2552-2561, 2006.
105. A. Zeller, M. V. Wenzl, M. Beretta et al., Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angelis salt, Molecular Pharmacology, vol. 76, no. 5, pp. 1115-1122, 2009.
106. S. D. Brain and A. D. Grant, Vascular actions of calcitonin gene-related peptide and adrenomedullin, Physiological Reviews, vol. 84, no. 3, pp. 903-934, 2004.
107. M. Eberhardt, M. Dux, B. Namer et al., H2S and NO cooperatively regulate vascular tone by activating a neuroendocrine HNO-TRPA1-CGRP signalling pathway, Nature Communications, vol. 5, article 4381, 17 pages, 2014.
108. D. K. Mistry and C. J. Garland, Nitric oxide (NO)-induced activation of large conductance Ca2+-dependent K+ channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery, British Journal of Pharmacology, vol. 124, no. 6, pp. 1131-1140, 1998.
109. Z. Chen, J. Zhang, and J. S. Stamler, Identification of the enzymaticmechanism of nitroglycerin bioactivation, Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 12, pp. 8306-8311, 2002.
110. C. G. Tocchetti, W. Wang, J. P. Froehlich et al., Nitroxyl improves cellular heart function by directly enhancing cardiac sarcoplasmic reticulumCa2+ cycling, Circulation Research, vol. 100, no. 1, pp. 96-104, 2007.
111. J. P. Froehlich, J. E. Mahaney, G. Keceli et al., Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl, Biochemistry, vol. 47, no. 50, pp. 13150-13152, 2008.
112. T. Dai, Y. Tian, C. G. Tocchetti et al., Nitroxyl increases force development in rat cardiac muscle, Journal of Physiology, vol. 580, no. 3, pp. 951-960, 2007.
113. P. Pagliaro, D. Mancardi, R. Rastaldo et al., Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning, Free Radical Biology and Medicine, vol. 34, no. 1, pp. 33-43, 2003.
114. S. Shiva, J. H. Crawford, A. Ramachandran et al., Mechanisms of the interaction of nitroxyl with mitochondria, Biochemical Journal, vol. 379, no. 2, pp. 359-366, 2004.
115. Y.-J. Li and J. Peng, The cardioprotection of calcitonin generelated peptide-mediated preconditioning, European Journal of Pharmacology, vol. 442, no. 3, pp. 173-177, 2002.
116. N. Cao, Y. G. Wong, S. Rosli et al., Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo, Circulation:Heart Failure, vol. 8, no. 3, pp. 572-581, 2015.
117. E. Bermejo, D. A. Saenz, F. Alberto, R. E. Rosenstein, S. E. Bari, and M. A. Lazzari, Effect of nitroxyl on human platelets function,Thrombosis and Haemostasis, vol. 94, no. 3, pp. 578-584, 2005.
118. A. J. Norris, M. R. Sartippour, M. Lu et al., Nitroxyl inhibits breast tumor growth and angiogenesis, International Journal of Cancer, vol. 122, no. 8, pp. 1905-1910, 2008.
119. B. E. Lopez, C. E. Rodriguez, M. Pribadi, N. M. Cook, M. Shinyashiki, and J. M. Fukuto, Inhibition of yeast glycolysis by nitroxyl (HNO): a mechanism of HNO toxicity and implications to HNO biology, Archives of Biochemistry and Biophysics, vol. 442, no. 1, pp. 140-148, 2005.
120. B. E. Lopez, D. A. Wink, and J. M. Fukuto, The inhibition of glyceraldehyde-3-phosphate dehydrogenase by nitroxyl (HNO), Archives of Biochemistry and Biophysics, vol. 465, no. 2, pp. 430-436, 2007.
121. H. Kayed, J. Kleeff, A. Kolb et al., FXYD3 is over expressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth, International Journal of Cancer, vol. 118, no. 1, pp. 43-54, 2006.
122. J. P. Froehlich and N. Paolocci, Up-regulated expression of the MAT-8 gene in prostate cancer and its siRNA-mediated inhibition of expression induces a decrease in proliferation of human prostate carcinoma cells, International Journal of Oncology, vol. 24, no. 1, pp. 97-105, 2004.
123. K. J. Sweadner and E. Rael, The FXYD gene family of small ion transport regulators or channels: cDNA sequence, protein signature sequence, and expression, Genomics, vol. 68, no. 1, pp. 41-56, 2000.
124. A. Ashkenazi and V. M. Dixit, Apoptosis control by death and decoy receptors, Current Opinion in Cell Biology, vol. 11, no. 2, pp. 255-260, 1999.
125. J. P. F. L. Paolocci, Use of Nitroxyl (HNO) for the Treatment of Cancers over Expressing MAT-8, U. S. P. Office, 2009.
126. B. E. Lopez, M. Shinyashiki, T. H. Han, and J. M. Fukuto, Antioxidant actions of nitroxyl (HNO), Free Radical Biology and Medicine, vol. 42, no. 4, pp. 482-491, 2007.
127. W.-K. Kim, Y.-B. Choi, P. V. Rayudu et al., Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO, Neuron, vol. 24, no. 2, pp. 461-469, 1999.
128. C. A. Colton, M. Gbadegesin, D. A. Wink, K. M. Miranda, M. G. Espey, and S. Vicini, Nitroxyl anion regulation of the NMDA receptor, Journal ofNeurochemistry, vol. 78, no. 5, pp. 1126-1134, 2001.
129. A. J. Vaananen, E. Kankuri, and P. Rauhala, Nitric oxiderelated species-induced protein oxidation: reversible, irreversible, and protective effects on enzyme function of papain, Free Radical Biology and Medicine, vol. 38, no. 8, pp. 1102-1111, 2005.
130. A. J. Vaananen, P. Salmenpera, M. Hukkanen et al., Persistent susceptibility of cathepsin B to irreversible inhibition by nitroxyl (HNO) in the presence of endogenous nitric oxide, Free Radical Biology and Medicine, vol. 45, no. 6, pp. 749-755, 2008.
131. A. J. Vaananen, P. Salmenpera, M. Hukkanen, P. Rauhala, and E. Kankuri, Cathepsin B is a differentiation-resistant target for nitroxyl (HNO) in THP-1 monocyte/macrophages, Free Radical Biology and Medicine, vol. 41, no. 1, pp. 120-131, 2006.
132. N. M. Cook, M. Shinyashiki, M. I. Jackson, F. A. Leal, and J. M. Fukuto, Nitroxyl-mediated disruption of thiol proteins: inhibition of the yeast transcription factor Ace1, Archives of Biochemistry and Biophysics, vol. 410, no. 1, pp. 89-95, 2003.
133. A. J. Vaananen, M. Moed, R. K. Tuominen et al., Angelis salt induces neurotoxicity in dopaminergic neurons in vivo and in vitro, Free Radical Research, vol. 37, no. 4, pp. 381-389, 2003.
134. A. J. Vaananen, R. Liebkind, E. Kankuri, P. Liesi, and P. Rauhala, Angelis salt and spinal motor neuron injury, Free Radical Research, vol. 38, no. 3, pp. 271-282, 2004.